Patent

The Patents Court, in the course of a dispute concerning the ability of the claimant company (FKB) to launch a generic drug of its own once the defendants’ supplementary protection certificate had expired, dismissed the defendants’ application for summary judgment. It held that FKB had a real prospect of success and that the UK courts had jurisdiction over FKB’s application for a declaration against the first defendant.